YOLFTbeta
Celldex Therapeutics Inc

Celldex Therapeutics Inc

CLDX · NASDAQ · Healthcare / Biotechnology

28.83USD+0.30 (+1.05%)

Price History

Full chart

Market Stats

Previous Close28.53
Open28.41
Day Range28.00 – 28.95
52-Week Range22.10 – 45.14
Volume544.30K
Market Cap2.44B
P/E (TTM)0.00
Forward P/E0.00
EPS-4.35
Dividend Yield0.00%
Beta0.84
50-Day Avg38.72
200-Day Avg32.23

About

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Anthony S. Marucci M.B.A.
  • Employees198
  • HeadquartersPerryville III Building, Hampton, NJ, United States, 08827, USA
  • Websitehttps://www.celldex.com

Leadership

  • Mr. Anthony S. Marucci M.B.A.Founder, President, CEO & Director · b. 1962
  • Dr. Tibor Keler Ph.D.Founder, Chief Scientific Officer & Executive VP · b. 1959
  • Mr. Sam Martin CPASenior VP, CFO, Secretary & Treasurer · b. 1971
  • Ms. Elizabeth CrowleyChief Product Development Officer & Senior VP · b. 1972
  • Dr. Margo Heath-Chiozzi M.D.Senior Vice President of Regulatory Affairs · b. 1957
  • Prof. Joseph P. Schlessinger Ph.D.Co-Founder & Member of Scientific Advisory Board · b. 1945
  • Ms. Sarah CavanaughSenior Vice President of Corporate Affairs & Administration · b. 1975
  • Mr. Freddy A. Jimenez Esq.Senior VP & General Counsel · b. 1969
  • Dr. Ronald A. Pepin Ph.D.Chief Business Officer & Senior VP · b. 1956
  • Dr. Diane C. Young M.D.Senior VP & Chief Medical Officer · b. 1957

Financials

Income Statement

Currency: USD1986-12-311987-12-311988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.20M4.60M10.90M10.20M10.20M8.90M6.60M9.00M7.00M4.00M1.10M1.20M2.20M1.48M763.20K3.35M6.70M4.63M6.86M3.09M4.93M5.10M7.46M15.18M46.79M9.27M11.20M4.11M3.59M5.48M6.79M12.74M9.54M3.57M7.42M4.65M2.36M6.88M7.02M1.50M
Growth (%)-+109.09%+136.96%-6.42%0.00%-12.75%-25.84%+36.36%-22.22%-42.86%-72.50%+9.09%+83.33%-32.57%-48.55%+338.40%+100.39%-30.90%+48.04%-54.97%+59.67%+3.48%+46.10%+103.61%+208.25%-80.20%+20.91%-63.30%-12.77%+52.82%+23.83%+87.78%-25.15%-62.54%+107.61%-37.30%-49.32%+192.02%+1.99%-78.63%
Cost of Revenue-100.00K300.00K800.00K800.00K1.10M1.10M600.00K1.50M1.20M1.20M-100.00K-300.00K-400.00K-712.80K-689.30K36.80K41.00K--8.68M17.64M24.51M38.92M8.40M12.08M9.12M10.78M2.33M3.40M4.01M102.03M96.17M66.45M42.67M42.53M53.31M82.26M118.01M163.55M-
Gross Profit2.30M4.30M7.00M10.10M9.10M9.10M6.00M7.50M5.80M2.80M1.20M1.50M2.60M2.20M1.45M3.31M6.66M4.63M6.86M3.09M4.93M5.10M7.46M6.78M34.72M146.00K427.00K1.78M185.00K1.47M-95.24M-83.43M-56.91M-39.10M-35.12M-48.66M-79.90M-111.13M-156.53M1.50M
Gross Margin104.55%93.48%64.22%99.02%89.22%102.25%90.91%83.33%82.86%70.00%109.09%125.00%118.18%148.05%190.32%98.90%99.39%100.00%100.00%100.00%100.00%100.00%100.00%44.68%74.19%1.58%3.81%43.23%5.16%26.81%-1403.48%-654.70%-596.68%-1094.29%-473.39%-1046.23%-3389.94%-1614.53%-2229.77%100.00%
Operating Expense3.90M6.30M8.90M14.50M13.50M15.60M10.70M16.90M15.30M14.60M13.00M9.20M10.55M14.14M16.89M27.87M21.10M16.37M20.44M21.95M27.30M27.96M41.46M39.64M41.17M43.55M58.50M83.22M122.61M131.01M37.68M38.10M99.53M15.93M28.24M22.58M35.33M43.41M38.55M288.90M
Operating Income-1.60M-2.00M-1.90M-4.40M-4.40M-6.50M-4.70M-9.40M-9.50M-11.80M-11.80M-7.70M-7.95M-11.94M-15.44M-24.56M-14.43M-11.73M-13.58M-18.87M-22.37M-22.85M-34.00M-32.85M-6.46M-43.40M-58.08M-81.44M-122.43M-129.54M-132.92M-121.53M-156.44M-55.03M-63.35M-71.24M-115.23M-154.54M-195.08M-287.40M
Operating Margin-72.73%-43.48%-17.43%-43.14%-43.14%-73.03%-71.21%-104.44%-135.71%-295.00%-1072.73%-641.67%-361.35%-805.14%-2023.17%-734.07%-215.25%-253.28%-198.03%-610.85%-453.60%-447.88%-456.04%-216.43%-13.79%-468.42%-518.45%-1981.08%-3414.11%-2363.89%-1958.68%-953.68%-1640.13%-1540.19%-854.06%-1531.78%-4889.01%-2245.27%-2778.89%-19160.00%
EBITDA-1.80M-1.30M-1.40M-3.80M-5.90M-5.90M-4.10M-8.50M-8.70M-11.10M-11.30M-7.31M-6.95M-9.96M-14.13M-22.30M-12.81M-10.21M-11.82M-16.50M-18.16M-19.07M-44.96M-33.07M4.67M-38.84M-54.41M-77.68M-114.68M-125.53M-124.44M-104.02M-72.60M-49.67M-45.64M-66.08M-104.20M-139.03M-154.69M-255.42M
EBITDA Margin-81.82%-28.26%-12.84%-37.25%-57.84%-66.29%-62.12%-94.44%-124.29%-277.50%-1027.27%-608.99%-315.89%-671.10%-1851.42%-666.61%-191.05%-220.31%-172.27%-534.43%-368.24%-373.73%-603.09%-217.85%9.97%-419.23%-485.72%-1889.52%-3197.96%-2290.69%-1833.75%-816.27%-761.20%-1390.06%-615.30%-1420.77%-4420.87%-2019.96%-2203.50%-17028.00%
Net Income-1.20M-1.10M-1.00M-3.40M-3.40M-4.60M-3.60M-7.80M-11.60M-8.30M-10.80M-13.10M-51.80M-11.31M-21.98M-22.75M-13.83M-12.67M-13.20M-18.10M-20.37M-21.64M-47.50M-36.52M-2.53M-44.80M-59.12M-81.55M-118.08M-127.20M-128.53M-93.03M-151.18M-50.88M-59.78M-70.51M-112.33M-141.43M-157.86M-258.80M
Net Income Margin-54.55%-23.91%-9.17%-33.33%-33.33%-51.69%-54.55%-86.67%-165.71%-207.50%-981.82%-1091.67%-2354.55%-762.33%-2879.32%-680.03%-206.26%-273.47%-192.51%-585.96%-413.17%-424.05%-637.12%-240.61%-5.41%-483.53%-527.79%-1983.70%-3292.81%-2321.11%-1894.05%-730.06%-1585.07%-1423.96%-805.88%-1516.04%-4765.59%-2054.76%-2248.76%-17253.33%
R&D--------8.70M8.00M6.00M5.30M5.70M7.87M10.77M21.58M14.71M10.02M13.87M14.06M18.07M18.50M26.35M26.17M27.65M32.44M47.40M67.40M104.38M100.17M102.73M96.17M66.45M42.67M40.53M56.81M82.26M118.01M163.55M245.10M
R&D as % of Total Revenue--------124.29%200.00%545.45%441.67%259.09%530.62%1411.71%644.98%219.37%216.31%202.28%455.37%366.38%362.45%353.39%172.39%59.09%350.12%423.12%1639.53%2910.79%1827.94%1513.79%754.70%696.68%1194.29%546.43%1221.48%3489.94%1714.53%2329.77%16340.00%
Interest Expense000000000000000000004.23M2.19M156.00K452.00K1.34M1.80M1.58M927.00K00015.97M151.09M018.82M112.00K2.91M---
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%85.71%42.96%2.09%2.98%2.86%19.38%14.07%22.55%0.00%0.00%0.00%125.34%1584.08%0.00%253.72%2.41%123.42%---

Balance Sheet

Currency: USD1986-12-311987-12-311988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets14.60M13.00M13.20M15.60M13.20M13.20M22.40M33.10M20.70M18.50M17.20M9.80M22.70M19.88M63.56M53.48M35.23M31.31M45.80M36.45M61.48M37.65M69.79M140.36M109.94M97.99M125.54M347.10M248.01M337.58M383.36M315.62M155.81M122.93M235.84M444.65M352.74M465.63M792.34M582.98M
Total Liabilities4.20M3.70M4.80M2.50M2.80M2.80M2.40M4.00M3.10M2.50M1.60M3.50M3.90M2.47M9.63M8.22M3.89M3.39M7.40M15.56M59.32M56.69M51.66M66.60M34.69M29.27M29.77M27.30M36.35M47.48M117.93M79.25M31.75M28.91M26.48M25.18M26.53M36.46M45.34M55.82M
Total Equity10.40M9.30M8.40M13.10M10.40M10.40M19.70M29.10M17.60M16.00M15.60M6.30M18.80M17.41M53.93M45.27M31.34M27.92M38.41M20.89M2.16M-19.04M18.13M73.77M75.25M68.72M95.77M319.80M211.66M290.11M265.43M236.37M124.06M94.03M209.36M419.48M326.20M429.17M747.00M527.16M
Cash13.50M10.80M9.60M11.30M8.70M8.70M3.30M28.30M7.60M12.30M12.60M6.40M8.90M13.62M50.18M42.67M25.07M20.25M31.74M23.42M40.91M15.66M44.26M57.00M21.29M11.90M24.90M169.40M28.02M72.11M42.46M40.29M24.31M11.23M43.84M39.14M29.43M34.81M28.36M28.87M
Total Debt-------500.00K500.00K200.00K-1.60M1.60M562.90K274.50K---186.51K217.46K4.64M5.17M1.04M13.84M23.02M15.36M11.34M-2.59M4.42M-6.57M4.53M3.66M3.48M3.04M4.03M2.54M3.81M2.34M
Net Debt-13.50M-10.80M-9.60M-11.30M-8.70M-8.70M-3.30M-27.80M-7.10M-12.10M-12.60M-4.80M-7.30M-13.06M-49.90M-42.67M-25.07M-20.25M-29.64M-23.20M-36.27M-10.49M-43.27M-43.16M-11.29M3.46M-13.56M-169.40M-25.43M-67.69M-42.46M-33.72M-19.78M-7.58M-40.35M-36.10M-25.40M-32.27M-24.54M-26.54M

Cash Flow

Currency: USD1986-12-311987-12-311988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow12.30M--700.00K-700.00K-3.00M-3.00M-3.90M-5.50M-9.10M-7.90M-9.70M-7.70M-8.90M-8.54M-4.43M-20.83M-16.66M-11.74M-10.35M-6.02M27.00M-19.30M18.28M-29.87M-30.37M-35.66M-49.78M-67.67M-101.54M-98.89M-113.04M-99.93M-75.23M-46.41M-40.40M-60.91M-103.73M-107.29M-157.78M-210.94M
Investing Cash Flow---900.00K-900.00K--400.00K-3.60M11.80M11.60M5.90M-200.00K1.50M7.60M3.27M-966.20K-775.40K-840.60K-2.21M-1.66M-2.17M-9.31M-5.71M10.16M45.09M-16.16M-2.15M-16.98M-77.42M-41.01M-50.19M68.91M46.47M29.82M17.08M-98.22M-216.16M89.94M-105.78M-290.13M209.07M
Financing Cash Flow--3.40M3.40M800.00K800.00K300.00K17.70M-6.70M10.20M-3.70M9.95M41.96M14.09M-95.20K9.13M25.50M-131.66K-198.42K-239.76K10.93M-2.46M10.82M28.43M79.76M289.60M1.17M193.15M14.48M51.29M29.44M16.26M171.23M272.37M4.08M218.46M441.45M2.39M
Capital Expenditure00700.00K700.00K400.00K400.00K500.00K500.00K800.00K600.00K600.00K100.00K300.00K688.50K177.20K605.20K567.70K210.10K6.00K09.32M4.98M1.30M528.00K2.10M509.00K303.00K4.22M1.93M4.88M2.75M1.79M813.00K731.00K1.55M1.25M1.83M1.82M1.92M2.71M
Free Cash Flow12.30M--1.40M-1.40M-3.40M-3.40M-4.40M-6.00M-9.90M-8.50M-10.30M-7.80M-9.20M-9.23M-4.61M-21.43M-17.23M-11.95M-10.34M-6.02M17.68M-24.28M16.98M-30.40M-32.47M-36.17M-50.09M-71.89M-103.47M-103.76M-115.79M-101.72M-76.05M-47.15M-41.96M-62.16M-105.56M-109.11M-159.70M-213.66M
Dividends Paid-------------------------0000000--------
FCF to OCF100.00%-200.00%200.00%113.33%113.33%112.82%109.09%108.79%107.59%106.19%101.30%103.37%108.06%104.00%102.91%103.41%101.79%99.94%100.00%65.46%125.78%92.86%101.77%106.91%101.43%100.61%106.23%101.90%104.93%102.43%101.79%101.08%101.57%103.84%102.05%101.76%101.69%101.22%101.29%
Dividend Paid to FCF-------------------------0.00%0.00%0.00%0.00%0.00%0.00%0.00%--------

Earnings

Report DateMay 12, 1993Oct 29, 1993May 2, 1994Aug 2, 1994Nov 10, 1994Feb 15, 1995May 12, 1995Aug 11, 1995Nov 10, 1995Feb 27, 1996Jul 23, 1996Nov 6, 1996Feb 19, 1997Mar 31, 1998Jun 30, 1998Sep 30, 1998Mar 31, 1999Jun 30, 1999Sep 30, 1999Apr 27, 2000Jun 30, 2000Oct 25, 2000Mar 1, 2001Apr 25, 2001Aug 2, 2001Oct 25, 2001Feb 26, 2002Apr 24, 2002Jul 24, 2002Oct 23, 2002Feb 26, 2003Apr 30, 2003Jul 23, 2003Oct 22, 2003Feb 24, 2004Apr 21, 2004Jul 22, 2004Oct 20, 2004Mar 2, 2005May 5, 2005Aug 3, 2005Oct 27, 2005Mar 8, 2006May 9, 2006Aug 2, 2006Nov 1, 2006Mar 7, 2007May 3, 2007Aug 2, 2007Oct 31, 2007Feb 27, 2008May 19, 2008Aug 6, 2008Nov 5, 2008Feb 27, 2009May 5, 2009Aug 5, 2009Nov 4, 2009Mar 4, 2010May 4, 2010Aug 4, 2010Nov 2, 2010Mar 3, 2011May 4, 2011Aug 3, 2011Nov 2, 2011Mar 7, 2012May 3, 2012Aug 10, 2012Nov 1, 2012Mar 7, 2013May 2, 2013Aug 6, 2013Nov 8, 2013Mar 3, 2014May 1, 2014Aug 6, 2014Nov 4, 2014Feb 24, 2015Apr 29, 2015Aug 10, 2015Nov 5, 2015Feb 23, 2016May 5, 2016Aug 8, 2016Nov 7, 2016Mar 14, 2017May 9, 2017Aug 8, 2017Nov 7, 2017Mar 7, 2018May 10, 2018Aug 8, 2018Nov 7, 2018Mar 7, 2019May 7, 2019Aug 7, 2019Nov 12, 2019Mar 26, 2020May 6, 2020Aug 6, 2020Nov 5, 2020Mar 29, 2021May 6, 2021Aug 5, 2021Nov 9, 2021Feb 28, 2022May 5, 2022Aug 8, 2022Nov 9, 2022Feb 28, 2023May 4, 2023Aug 8, 2023Nov 2, 2023Feb 26, 2024May 6, 2024Aug 8, 2024Nov 6, 2024Feb 24, 2025May 8, 2025Aug 7, 2025Nov 10, 2025Mar 2, 2026May 7, 2026Aug 6, 2026Nov 9, 2026
EPS Estimate-18.00-21.60-25.20-25.20-24.30-35.10-23.40-25.20-27.00-25.20-18.00-18.00-18.00-------10.80--10.80-13.50-16.20-22.80-24.60-20.40-18.00-18.00-17.10-12.60---10.80-9.00-9.00-9.00--10.80-5.40-6.30-12.60-10.80-7.20-12.60-12.60-14.40-14.40-18.00-12.60--19.95-8.40-6.22-8.10-6.90-7.10-7.85-4.42-3.95-3.95-4.873.15-4.35-4.09-3.75-4.17-3.69-3.69-3.69-3.75-3.60-3.45-3.70-4.18-3.75-3.90-4.85-5.28-5.25-5.20-5.18-5.14-5.23-5.03-5.00-5.04-4.31-4.17-4.01-3.71-3.03-2.70-2.55-1.20-1.14-1.17-0.84-0.90-0.72-0.58-0.38-0.37-0.37-0.40-0.35-0.42-0.43-0.42-0.57-0.59-0.60-0.66-0.66-0.74-0.67-0.59-0.67-0.71-0.74-0.86-0.89-1.00-1.13-1.04-1.02
EPS Actual-23.40-27.00-19.80-23.40-23.40-19.80-25.20-27.00-32.40-28.80-39.60-18.00-16.20-9.52-8.22-242.45-11.61-9.97-10.65-7.20-9.79-12.60-14.40-12.60-18.00-19.80-19.80-14.40-16.20-1.80-10.80-10.01-9.48-5.40-9.00-5.40-9.00-8.98-9.00-12.60-10.80-10.80-9.00-7.20-14.40-14.40-14.40-12.60-10.80-12.60-26.19-32.85-10.05-7.50-7.05-7.95-7.35-6.75-6.45-3.15-3.90-4.20-3.60-4.80-4.05-4.05-4.35-4.05-3.45-3.75-4.05-3.45-3.60-4.35-4.05-4.95-4.80-4.65-5.40-4.95-4.95-4.80-4.95-5.25-4.80-4.35-4.50-4.20-3.45-3.00-2.55-12.60-1.65-0.60-0.81-1.40-0.84-0.75-0.64-0.73-0.57-0.36-0.55-0.42-0.34-0.37-0.43-0.50-0.58-0.57-0.56-0.62-0.65-0.81-0.83-0.56-0.54-0.64-0.71-0.81-0.85-1.01-1.22-1.18-0.94-
Surprise-30.00%-25.00%21.43%7.14%3.70%43.59%-7.69%-7.14%-20.00%-14.29%-120.00%0.00%10.00%------33.33%--16.67%-6.67%22.22%21.05%19.51%2.94%20.00%10.00%89.47%14.29%--50.00%0.00%40.00%0.00%-16.67%-133.33%-71.43%14.29%16.67%0.00%-14.29%-14.29%0.00%12.50%40.00%0.00%--64.66%-19.64%-20.58%12.96%-15.22%-3.52%14.01%-45.93%20.25%1.27%13.76%-214.29%-10.34%0.98%-8.00%-4.32%-9.76%6.50%-1.63%-8.00%4.17%-4.35%-17.57%3.11%-32.00%-23.08%4.12%-2.27%5.71%4.81%7.34%3.70%-0.38%4.57%13.00%10.71%2.55%17.27%25.19%31.27%-315.84%38.89%76.47%32.50%-22.81%28.21%10.71%28.89%-1.39%1.72%5.26%-48.65%-13.51%15.00%-5.71%-2.38%-16.28%-38.10%0.00%5.08%-3.33%1.52%-22.73%-12.16%16.42%8.47%4.48%0.64%-9.46%1.16%-13.48%-22.00%-4.42%9.62%-
TimingPre-marketPre-market-------------------Pre-market---Pre-market-Pre-marketPre-marketPre-marketPre-market--Pre-market-Pre-marketPre-market--Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-After-hoursPre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap2.44B
Enterprise Value1.73B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales15457.40
Price / Book3.68
EPS-4.35
Book Value9.10
Revenue (TTM)158.00K
Gross Profit (TTM)-278.65M
EBITDA-322.43M
Profit Margin0.00%
Operating Margin-366468.20%
Return on Equity-43.88%
Return on Assets-27.62%
Shares Outstanding78.53M
Shares Float73.02M
Beta0.84
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 15 analystsTarget 62.50
  • Strong Buy
    12
  • Buy
    2
  • Hold
    1

Ownership Breakdown

Institutions
110.27%
Insiders
0.27%
Retail / Other
0.00%

Top Institutional Holders

  • Wellington Management Company LLP
    9.54M12.16%
  • BlackRock Inc
    5.37M6.84%
  • Kynam Capital Management, LP
    5.32M6.78%
  • FMR Inc
    3.75M4.78%
  • Point72 Asset Management, L.P.
    3.23M4.11%
  • Vanguard Capital Management, LLC
    2.96M3.77%
  • Deep Track Capital, LP
    2.94M3.74%
  • State Street Corp
    2.80M3.57%
  • COMMODORE CAPITAL LP
    2.70M3.44%
  • Logos Global Management LP
    2.10M2.68%
  • T. Rowe Price Associates, Inc.
    2.09M2.66%
  • Eversept Partners, LP
    1.79M2.28%
  • Geode Capital Management, LLC
    1.69M2.15%
  • BRAIDWELL LP
    1.36M1.73%

Top Fund Holders

  • Vanguard Health Care Inv
    4.28M5.45%
  • Vanguard MStar Total Stk Mkt Idx Invest
    2.50M3.18%
  • State Street® SPDR® S&P® Biotech ETF
    2.13M2.72%
  • iShares Russell 2000 ETF
    2.01M2.56%
  • Vanguard Explorer Inv
    1.45M1.84%
  • T. Rowe Price New Horizons
    1.25M1.59%

Stock Splits

  • Feb 11, 20191:15
  • Mar 10, 20081:12